Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
News Archive
News Archive Navigation
News Archive Navigation Language
May 2018
-
Women in Science: Mimi Huizinga
Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
-
Machine learning poised to accelerate drug discovery
Technology used to tag friends on social media could change the way drug discovery is done.
-
T.J. Sharpe on why clinical trials matter
Melanoma survivor T.J. Sharpe discusses the importance of clinical trials to help raise awareness among the community.
April 2018
-
African experts call for renewed global drive to beat malaria
Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
-
Two decades of volunteering at Novartis
The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.
-
Meet Martin Grobusch, malaria fighter
One man’s fascination with malaria helps fuel the search for new treatments.
-
DNA-encoded molecules provide a new edge in cancer drug hunts
Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.
March 2018
-
Malaria is still disrupting lives, despite progress
The disease hobbles families and economies.
-
Building “boot camps” for immune cells near tumors
Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
-
Positive gains are needed to accelerate change for women with lung disease
COPD receives low attention as a women’s health issue. It’s time to change that.
February 2018
-
Taking on obesity
Novartis is developing an experimental drug for weight loss.
-
Potential weight loss treatment takes shape with help from patients
Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
Pagination
- ‹ Previous page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- …
- 33
- › Next page
Test disclaimer...!!!